(Press-News.org) UPTON, NY - Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have identified key elements in the biochemical mechanism plants use to limit the production of fatty acids. The results suggest ways scientists might target those biochemical pathways to increase the production of plant oils as a renewable resource for biofuels and industrial processes.
"Now that we understand how this system operates - how plants 'know' when they've made enough oil and how they slow down production - we can look for ways to break the feedback loop so they keep making more oil," said Brookhaven biochemist John Shanklin, leader of the group publishing the work in the Proceedings of the National Academy of Sciences the week of June 4, 2012.
Similar biochemical feedback loops regulate a wide range of metabolic processes in living things. They work similar to the way a thermostat maintains a relatively constant temperature in your home: When it gets too warm, the heating system turns off until the temperature falls to the set point, at which time it turns on again.
"There were hints that such a feedback system might exist for plant oil production," said Shanklin, who credits Carl Andre - a former postdoctoral research fellow now working at BASF Plant Science in North Carolina - with designing and carrying out the intricate biochemical detective work that uncovered the details.
"It's very difficult to work on developing oil seeds because they are very tiny," Shanklin explained. So the scientists performed their biochemical tests using a plant embryo cell culture to simulate what goes on in the seeds.
With assistance from the Radiotracer Chemistry and Biological Imaging group at Brookhaven (http://www.bnl.gov/medical/RCIBI/), Andre synthesized "labeled" forms of the fatty acids that occur as intermediates along the metabolic pathway that leads to oil production. He fed these, one at a time, to the plant cell cultures, measuring the labeled metabolites with the help of analytic chemist Richard Haslam of Rothamsted Research in the UK. They also looked to see which added intermediates would inhibit oil production.
Andre's work pointed to a fatty acid that occurs fairly late in the production process, coupled to a carrier protein (essential to making the oily substance soluble in water), as the key intermediate that puts the brakes on oil production. It's the first "desaturated" fatty acid - the first one with a double bond between two of the carbon atoms, formed after all 18 carbon atoms are added to the chain.
Then, knowing that this intermediate somehow sent the "slow-down" signal, the team sought to determine its "target" - how it actually inhibits oil synthesis. They knew from other biochemical feedback loops that the likely target would be an enzyme early in the synthesis pathway. But they wanted to figure out exactly which one.
To do this, they monitored the production process by labeling the intermediates one at a time with a radioactive form of carbon while also feeding the cells an excess of the "slow-down" signaling fatty acid. If the label from the intermediate ended up in the oil product, the "slow-down" signal had to have its effect prior to that step.
The first two experiments gave them the answer: When they labeled the first compound in the synthesis pathway, which is acetate, very little labeled carbon ended up in the oil and oil production was strongly reduced. But if they fed the second compound, labeled malonate, the labeled carbon quickly entered the oil.
"From these findings we concluded that the accumulation of the first desaturated fatty acid in the synthesis process inhibits the enzyme that operates at the first step, which converts acetate to malonate," Shanklin said. "That enzyme is Acetyl-CoA carboxylase, or ACCase."
The next step was to make extracts of the tissue culture and directly measure ACCase activity in the test tube. Addition of the suspected slow-down signal provided independent proof that both the signal and target of the signal were correctly identified.
To establish that this feedback mechanism operates in seeds and is not just a weird quirk of the cell-culture setup, the scientists isolated developing canola embryos to test the process. "It worked precisely the same way," Shanklin said.
With the details of the oil production feedback mechanism in hand, Shanklin's team is now exploring how they might interfere with the process, including biochemical schemes to keep the "slow-down" signaling metabolite from accumulating, ways to block its effects on ACCase, and more.
"If we can interrupt this process, we hope to fool the cells so they won't be able to gauge how much oil they have made and will make more," Shanklin said.
INFORMATION:
This research was funded by the DOE Office of Science and Bayer CropScience.
DOE's Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit: http://science.energy.gov/.
One of ten national laboratories overseen and primarily funded by the Office of Science of the U.S. Department of Energy (DOE), Brookhaven National Laboratory conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies and national security. Brookhaven Lab also builds and operates major scientific facilities available to university, industry and government researchers. Brookhaven is operated and managed for DOE's Office of Science by Brookhaven Science Associates, a limited-liability company founded by the Research Foundation of State University of New York on behalf of Stony Brook University, the largest academic user of Laboratory facilities, and Battelle, a nonprofit, applied science and technology organization.
Visit Brookhaven Lab's electronic newsroom for links, news archives, graphics, and more at http://www.bnl.gov/newsroom , or follow Brookhaven Lab on Twitter, http://twitter.com/BrookhavenLab .
END
SANTA CRUZ, CA--Giant insects ruled the prehistoric skies during periods when Earth's atmosphere was rich in oxygen. Then came the birds. After the evolution of birds about 150 million years ago, insects got smaller despite rising oxygen levels, according to a new study by scientists at the University of California, Santa Cruz.
Insects reached their biggest sizes about 300 million years ago during the late Carboniferous and early Permian periods. This was the reign of the predatory griffinflies, giant dragonfly-like insects with wingspans of up to 28 inches (70 centimeters). ...
ROCHESTER, Minn. -- Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; people whose immune systems produce too much of the molecule are far more likely to die of a life-threatening illness such as cancer, diabetes and cardiac and respiratory disease than those whose bodies make normal levels. The study is published in the June issue of Mayo Clinic Proceedings.
Researchers studied blood samples ...
Rochester, MN, June 4, 2012 – Micah True, legendary ultra-marathoner, died suddenly while on a routine 12-mile training run March 27, 2012. The mythic Caballo Blanco in the best-selling book, Born to Run, True would run as far as 100 miles in a day. On autopsy his heart was enlarged and scarred; he died of a lethal arrhythmia (irregularity of the heart rhythm). Although speculative, the pathologic changes in the heart of this 58 year-old veteran extreme endurance athlete may have been manifestations of "Phidippides cardiomyopathy," a condition caused by chronic excessive ...
PROVIDENCE, R.I. [Brown University] — Nobody wins when patients stay in the hospital unnecessarily, so the federal government in recent years has pushed hospitals to be careful about admitting Medicare recipients as inpatients. The apparent result is that more patients are being "held for observation" instead, according to a new study by Brown University gerontologists. While the shift in how hospitals care for elderly patients in the emergency department may reduce costs to Medicare, it can also increase out-of-pocket expenditures for patients.
"The dual trends of increasing ...
ANN ARBOR, Mich. — The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
Chemotherapy-induced peripheral neuropathy is a common side effect of certain chemotherapy drugs. The tingling feeling -- usually felt in the toes, feet, fingers and hands -- can be uncomfortable for many patients, but for about 30 percent of patients, it's a painful sensation. Previous studies have ...
Pittsburgh, PA…An international team of researchers has announced the discovery of Afrasia djijidae, a new fossil primate from Myanmar that illuminates a critical step in the evolution of early anthropoids—the group that includes humans, apes, and monkeys. The 37-million-year-old Afrasia closely resembles another early anthropoid, Afrotarsius libycus, recently discovered at a site of similar age in the Sahara Desert of Libya. The close similarity between Afrasia and Afrotarsius indicates that early anthropoids colonized Africa only shortly before the time when these animals ...
COLUMBUS, Ohio - Skin cancer patients whose childhood included periods of neglect or maltreatment are at a much greater risk for their cancers to return when they face a major stressful event, based on a new study.
The research suggests that such experiences during a person's youth can set a lower level of immune response for life, which in turn might make them more susceptible to the kind of cancers that are often successfully fought by the immune system, so-called immunogenic tumors.
While the research focused on patients with a fairly benign form of skin cancer -- ...
ROCHESTER, Minn. -- High doses of the herb American ginseng (Panax quinquefolius) over two months reduced cancer-related fatigue in patients more effectively than a placebo, a Mayo Clinic-led study found. Sixty percent of patients studied had breast cancer. The findings are being presented at the American Society of Clinical Oncology's annual meeting.
Researchers studied 340 patients who had completed cancer treatment or were being treated for cancer at one of 40 community medical centers. Each day, participants received a placebo or 2,000 milligrams of ginseng administered ...
STANFORD, Calif. — In a new study of the effects of soy supplements for postmenopausal women, researchers at the Stanford University School of Medicine and the USC Keck School of Medicine found no significant differences — positive or negative — in overall mental abilities between those who took supplements and those who didn't.
While questions have swirled for years around a possible link between soy consumption and changes in cognition, this research offers no evidence to support such claims. "There were no large effects on overall cognition one way or another," said ...
North Carolina's coordinated, regional systems for rapid care improved survival rates of patients suffering from the most severe heart attack, according to research in the American Heart Association's journal, Circulation.
Fewer ST -segment elevation myocardial infarction (STEMI) patients died when paramedics diagnosed them en route to hospitals and hospitals followed well-defined guidelines to quickly treat or transfer patients to facilities that performed artery-opening procedures, if needed. Death rates were 2.2 percent for patients treated to guideline standards and ...
